NORTH AMERICA NEWBORN SCREENING MARKET 2019-2027

MARKET OUTLOOK
Triton Market Research has estimated the North America newborn screening market to upsurge at a compound annual growth rate of 13.93% during the forecast period between 2019 and 2027. The countries of Canada and the US together constitute the newborn screening market for the North American region.
The increasing awareness about pediatric congenital heart diseases is expected to drive the demand for newborn screening tests. Newborn screening includes a series of tests which are performed on newborns for the early detection, diagnosis and management of diseases to prevent disability and death of a child. As per the Center for Disease Control and Prevention (U.S.) Report 2015, about 5,965 infants are estimated to be born each year with critical CHD in the United States. This growing number of congenital heart diseases is raising the awareness for pediatric congenital heart diseases and is expected to boost the adoption of newborn screening tests for early detection through screening. Congenital heart defects and preterm birth are the two leading causes of infant mortality. As per the WHO, in 2016, about 4.2 million (which accounts to 75% of all under the age of five) deaths occurred within the first year of life. Infant mortality globally in 2016 was about 30.5 deaths per 1000 live births.
COMPETITIVE OUTLOOK
Companies contending in the market are Natus Medical, Incorporated, GE Healthcare, Limited, Trivitron Healthcare, Bio-Rad Laboratories, Inc., Masimo Corporation, SCIEX, Waters Corporation, Thermo Fisher Scientific, Inc., BioTek Instruments, Inc., Medtronic Plc, Cardinal Health, Inc., ZenTech S.A., NeoGen Labs Pvt. Ltd., Agilent Technologies, Inc. and PerkinElmer, Inc.

TABLE OF CONTENT
1. NORTH AMERICA NEWBORN SCREENING MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1. SUPPORTIVE GOVERNMENT POLICIES IN THE US AND CANADA
2.2.2. DEMAND FOR NEWBORN SCREENING INSTRUMENTS IS RISING STEADILY
2.2.3. GROWTH IN DRY BLOOD SPOT TEST
2.2.4. TECHNIQUES USED IN NEWBORN SCREENING TESTS
2.3. EVOLUTION & TRANSITION OF NEWBORN SCREENING
2.4. PORTER’S FIVE FORCE ANALYSIS
2.4.1. THREAT OF NEW ENTRANTS
2.4.2. THREAT OF SUBSTITUTE
2.4.3. BARGAINING POWER OF SUPPLIERS
2.4.4. BARGAINING POWER OF BUYERS
2.4.5. THREAT OF COMPETITIVE RIVALRY
2.5. KEY IMPACT ANALYSIS
2.5.1. RELIABILITY
2.5.2. COST
2.5.3. AVAILABILITY
2.5.4. TECHNOLOGICAL ADVANCEMENT
2.6. MARKET ATTRACTIVENESS INDEX
2.7. VENDOR SCORECARD
2.8. INDUSTRY COMPONENTS
2.8.1. RAW MATERIAL SUPPLIERS
2.8.2. MANUFACTURERS
2.8.3. DISTRIBUTORS
2.8.4. END-USERS
2.9. REGULATORY FRAMEWORK
2.10. INDUSTRY PLAYER POSITIONING
2.11. KEY MARKET STRATEGIES
2.11.1. PRODUCT LAUNCH
2.12. MARKET DRIVERS
2.12.1. INCREASE IN OCCURRENCES OF NEWBORN DISEASES
2.12.2. GROWING NUMBER OF INFANTS WITH BIRTH DEFECT
2.12.3. BACKING OF GOVERNMENT TOWARDS NEWBORN CHILD HEALTH
2.12.4. RISING AWARENESS FOR PEDIATRIC CONGENITAL HEART DISEASE
2.13. MARKET RESTRAINTS
2.13.1. SOCIO-ECONOMIC HURDLES IN THE IMPLEMENTATION OF NEWBORN CHILD SCREENING
2.14. MARKET OPPORTUNITIES
2.14.1. NEWBORN SCREENING HELPS IN EARLY IDENTIFICATION AND MANAGEMENT OF AFFECTED NEWBORNS
2.14.2. TECHNOLOGICAL ADVANCEMENTS IN NEWBORN SCREENING
2.14.3. INCREASE IN NUMBER OF PREGNANT WOMEN WITH ADVANCED MATERNAL AGE
2.15. MARKET CHALLENGES
2.15.1. DEARTH OF SKILLED PROFESSIONAL IN HEALTHCARE INDUSTRY
2.15.2. MAINTENANCE OF EQUIPMENT IN HOSPITAL
3. NEWBORN SCREENING MARKET OUTLOOK - BY PRODUCT
3.1. NEWBORN SCREENING INSTRUMENTS
3.2. NEWBORN SCREENING REAGENTS & ASSAY KITS
4. NEWBORN SCREENING MARKET OUTLOOK - BY TEST TYPE
4.1. HEARING SCREEN TEST
4.2. CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST
4.3. DRY BLOOD SPOT TEST
5. NEWBORN SCREENING MARKET OUTLOOK - BY TECHNOLOGY
5.1. TANDEM MASS SPECTROMETRY
5.2. PULSE OXIMETRY
5.3. ENZYME-BASED ASSAYS
5.4. DNA-BASED ASSAYS
5.5. ELECTROPHORESIS
5.6. OTHERS
6. NEWBORN SCREENING MARKET - REGIONAL OUTLOOK
6.1. UNITED STATES
6.2. CANADA
7. COMPETITIVE LANDSCAPE
7.1. SCIEX
7.2. BIOTEK INSTRUMENTS, INC.
7.3. BIO-RAD LABORATORIES, INC.
7.4. CARDINAL HEALTH, INC.
7.5. GE HEALTHCARE, LIMITED
7.6. AGILENT TECHNOLOGIES, INC.
7.7. MASIMO CORPORATION
7.8. NATUS MEDICAL, INCORPORATED
7.9. MEDTRONIC PLC
7.10. THERMO FISHER SCIENTIFIC, INC.
7.11. NEOGEN LABS PVT. LTD.
7.12. PERKINELMER, INC.
7.13. ZENTECH S.A.
7.14. WATERS CORPORATION
7.15. TRIVITRON HEALTHCARE
8. METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY


LIST OF TABLES
TABLE 1: NORTH AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: LIST OF PRODUCT LAUNCHES
TABLE 6: LEADING CAUSE OF INFANT DEATHS IN THE UNITED STATES
TABLE 7: NORTH AMERICA NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)
TABLE 8: NORTH AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)
TABLE 9: NORTH AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)
TABLE 10: NORTH AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)


LIST OF FIGURES
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: KEY BUYING IMPACT ANALYSIS
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: INDUSTRY PLAYER POSITIONING IN 2018 (IN %)
FIGURE 5: NORTH AMERICA NEWBORN SCREENING MARKET, BY NEWBORN SCREENING INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 6: NORTH AMERICA NEWBORN SCREENING MARKET, BY NEWBORN SCREENING REAGENTS & ASSAY KITS, 2019-2027 (IN $ MILLION)
FIGURE 7: NORTH AMERICA NEWBORN SCREENING MARKET, BY HEARING SCREEN TEST, 2019-2027 (IN $ MILLION)
FIGURE 8: NORTH AMERICA NEWBORN SCREENING MARKET, BY CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST, 2019-2027 (IN $ MILLION)
FIGURE 9: NORTH AMERICA NEWBORN SCREENING MARKET, BY DRY BLOOD SPOT TEST, 2019-2027 (IN $ MILLION)
FIGURE 10: NORTH AMERICA NEWBORN SCREENING MARKET, BY TANDEM MASS SPECTROMETRY, 2019-2027 (IN $ MILLION)
FIGURE 11: NORTH AMERICA NEWBORN SCREENING MARKET, BY PULSE OXIMETRY, 2019-2027 (IN $ MILLION)
FIGURE 12: NORTH AMERICA NEWBORN SCREENING MARKET, BY ENZYME-BASED ASSAY, 2019-2027 (IN $ MILLION)
FIGURE 13: NORTH AMERICA NEWBORN SCREENING MARKET, BY DNA-BASED ASSAYS, 2019-2027 (IN $ MILLION)
FIGURE 14: NORTH AMERICA NEWBORN SCREENING MARKET, BY ELECTROPHORESIS, 2019-2027 (IN $ MILLION)
FIGURE 15: NORTH AMERICA NEWBORN SCREENING MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)
FIGURE 16: NORTH AMERICA NEWBORN SCREENING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 17: UNITED STATES NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 18: CANADA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)